Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Gang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2522-7987, 0000-0002-5337-3164; OpenAlex author ID A5100363247. Sources: OpenAlex.

Their work

Papers
9 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers · 2022: 4 papers · 2023: 1 paper

Papers 9

  1. Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner. Co-author DOI 10.1038/s41467-023-38578-3↗
  2. Subtyping for pancreatic cancer precision therapy. First author DOI 10.1016/j.tips.2022.03.005↗
  3. Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer: A Meta-analysis of Observational Studies. Last author DOI 10.1097/mpa.0000000000002143↗
  4. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. Co-author DOI 10.1136/jitc-2021-004129↗
  5. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine. First author DOI 10.1186/s40779-022-00416-w↗
  6. NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Co-author DOI 10.1038/s41467-021-24769-3↗
  7. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development. First author DOI 10.1186/s12943-021-01310-0↗
  8. Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy. Co-author DOI 10.1186/s13046-021-02055-w↗
  9. Split Cyclin-Dependent Kinase 4/6-Retinoblastoma 1 Axis in Pancreatic Cancer. First author DOI 10.3389/fcell.2020.602352↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xing Huang · 8 shared papers, 2020–2023 · strength 1.58
  2. Tingbo Liang · 7 shared papers, 2021–2023 · strength 1.34
  3. Tianyu Tang · 5 shared papers, 2021–2023 · strength 0.89
  4. Enliang Li · 2 shared papers, 2021 · strength 0.31
  5. Shuai Xu · 1 shared paper, 2022 · strength 0.20
  6. Zhengtao Hong · 1 shared paper, 2022 · strength 0.16
  7. Xiao Zhi · 1 shared paper, 2022 · strength 0.16
  8. Junming Huang · 1 shared paper, 2022 · strength 0.16
  9. Jian Xu · 1 shared paper, 2021 · strength 0.12
  10. Dipesh Kumar Yadav · 1 shared paper, 2021 · strength 0.12
  11. Xiaozhen Zhang · 1 shared paper, 2021 · strength 0.12
  12. Mengyi Lao · 1 shared paper, 2021 · strength 0.12
  13. Xueli Bai · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.